- The Healthcare Burnout Backlash (pt 1): Burnout Reaches Well Beyond Clinicians
- The Healthcare Burnout Backlash (pt 1): Burnout Reaches Well Beyond Clinicians
- Even Mild Oxygen Loss in Preemies' First Hours Poses Lifelong Brain Risks: Study
- 12 oral surgery updates in 2026
- 5 ASC, MOB deals in California
- Hidden OR capacity challenges: 8 perioperative leaders on what’s draining surgical time
- The Aspen Group’s 3-year growth recap: 40 moves
- Florida State University set to acquire Tallahassee hospital
- How Confusing Financial Journeys Undermine Revenue and Trust
- How Confusing Financial Journeys Undermine Revenue and Trust
- Misalignment, Not Malice: Rethinking Generational Conflict in Healthcare
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 8 Medicare Advantage numbers to know in 2026
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
City Journal (the old Manhattan Institute) boldly exposes the "other" Medicaid issue. DSH (pronounced "dish") is not only open to abuse, hospitals have been inflating numbers for years.
However, states' abuse of Medicaid is on an entirely higher level. (Yes, this is us, Michigan).
https://www.city-journal.org/article/medicaids-dark-money
Medicaid’s Dark Money
How states launder funds to evade program rules
A bipartisan group of 51 senators recently called for Congress to cancel an impending $8 billion cut to federal Medicaid allotments for “uncompensated” hospital care. No limit currently exists on the federal matching funds that states can claim to provide Medicaid benefits to eligible beneficiaries. The $8 billion cut would only trim the degree to which states can steer Medicaid funds away from the program’s covered benefits—often for purposes which Congress has specifically prohibited.
When Congress enacted Medicare in 1965 to provide health care for elderly Americans, it also established Medicaid, which gives states funds to provide health care to low-income Americans. For every $1 that states spent on health care for most eligible beneficiaries, the federal government gave them between $1 and $3—an enormously generous proposition, which all states were eager to exploit.
The federal government initially allowed hospitals to claim repayment for whatever broadly defined costs they incurred treating Medicare and Medicaid beneficiaries. Expenses surged. In the early 1980s, Congress responded by establishing specific Medicare fees for each hospital procedure and allowed states to set their own fees for hospitals to treat Medicaid patients.
Hospitals in low-income neighborhoods serving mostly Medicaid or uninsured patients struggled to cover their overhead costs by using revenues from privately insured patients, so Congress allowed states to claim additional federal matching funds as a lump sum to subsidize such “Disproportionate Share Hospitals” (DSH). In the early 1990s, states realized that the absence of a direct link between the ability to obtain matching funds and the obligation to deliver services gave them an opportunity to claim a windfall in federal funds. States would artificially inflate DSH costs by imposing taxes on hospitals, which would receive kickbacks for participating in the scam. DSH spending surged from $1 billion in 1990 to $17 billion in 1992, before Congress capped the funds that each state could claim. This entrenched an essentially arbitrary distribution of federal aid: in 2023, New Hampshire received $2,123 in DSH grants per poor resident; Wyoming, only $4.
After DSH allotments were capped, a similar supplemental supplemental-payment scheme was soon devised, whereby states that set base Medicaid fees for hospitals below Medicare rates could claim the difference as lump-sum grants. These “upper payment limit” federal funds could then be distributed to select hospitals to use for discretionary purposes, rather than in return for specific Medicaid-covered services. Hospitals then complained that they were underpaid for Medicaid patients—justifying additional subsidies.
Federal law allows states to finance up to 60 percent of their contribution to Medicaid from local government funds. As there is a constant flow of intergovernmental transfers between states, cities, and counties for various purposes, publicly owned hospitals are well suited to exploiting these rules by manipulating funding streams. Hospitals in New York, for example, receive more in Medicaid supplemental payments than those in any other state, and New York City’s municipal Health + Hospitals system has become particularly dependent on them. Medicaid supplemental payments accounted for 31 percent of all H+H revenues in 2016—a big deal for a system operating at an 8 percent loss.
Health + Hospitals runs 11 acute-care hospitals and 70 Community Health Centers, with a mission of delivering care to the city’s underserved and uninsured “regardless of race, immigration status, or ability to pay.” It treats 15 percent of Manhattan’s hospitalized patients but 72 percent of its uninsured. H+H delivers few lucrative surgical procedures to privately insured patients but provides the bulk of treatment for substance-abuse and psychiatric disorders.
H+H also uses its discretionary funds for an array of activities, ranging from “faith based initiatives” and “plant-based medicine” to after-school programs and housing aid, in an attempt to promote wellness and healthy living. Though federal law prohibits states from extending Medicaid benefits to even recent legal immigrants, supplemental payments have allowed H+H to deliver free health-care services to New York City’s half-million illegal immigrants. The city also uses H+H to fund health care for its jail inmates and prison staff—neither of whom are eligible for Medicaid.
Despite its supposed rationale, the bulk of Medicaid supplemental payments do not go to facilities serving low-income communities. Forty-three percent of all hospitals nationwide received DSH funds in 2017. In fact, a 2016 U.S. Government Accountability Office report concluded that “the bulk of supplemental payments to hospitals were made contingent on these hospitals or the relevant local government providing funds to finance the nonfederal share of the payments the hospitals received, rather than Medicaid services they provided.”
The 2010 Affordable Care Act sought to offset part of the cost of its insurance subsidy expansion by slashing DSH allotments. These cuts were to be concentrated on states with relatively high DSH expenditures, few uninsured residents, and weak targeting of funds at institutions providing uncompensated care—conditions that placed New York hospitals in the crosshairs for a $1.4 billion (66 percent) cut.
But Congress has repeatedly postponed the scheduled DSH cuts with broad bipartisan support, under the pretext that the ACA failed to reduce the number of uninsured as intended—with Republican legislators pointing to red states that had opted against expanding Medicaid, and Democrats eager to preserve grants that mostly went to blue states.
The hospital industry, which spent $125 million lobbying last year, has been eager to portray reduced DSH allotments as cuts to services. But in reality, the cuts would simply lead states to reallocate their DSH contributions to Medicaid base payments, which are not capped. Nothing prevents states from continuing to draw federal matching funds in return for state funds currently used for DSH, so long as they are used to pay for covered benefits.
The main consequence of allowing the scheduled cuts to take effect would therefore be to ensure that a larger proportion of Medicaid funds is reserved for eligible low-income beneficiaries, gets distributed to facilities serving such beneficiaries in a traceable manner, and is provided in return for delivering care for which the facilities can be held accountable. Medicaid dollars should be kept for Medicaid benefits, not diverted into a slush fund for states.
Christopher Pope is a senior fellow at the Manhattan Institute. Previously, he was director of policy research at West Health, a nonprofit medical research organization; health-policy fellow at the U.S. House Committee on Energy and Commerce; and research manager at the American Enterprise Institute. Pope’s research focuses on healthcare payment policy, and he has recently published reports on hospital-market regulation, entitlement design, and insurance-market reform. His work has appeared in, among others, the Wall Street Journal, Health Affairs, US News and World Report, and Politico.
Pope holds a B.Sc. in government and economics from the London School of Economics and an M.A. and Ph.D. in political science from Washington University in St. Louis.
In light of all the above, it has been interesting to watch big-government response to dinished Medicaid rolls since enforcement of rules for program qualification resumed post-COVID.
MDHHS has extended all sorts of gambits to increase sign-up.
Now from another level of government, I give you an email from US Representative Debbie Dingell.
Dear Friend,
According to Medicaid.gov, as of December 2023, over 85 million Americans were enrolled in Medicaid and the Children’s Health Insurance Program (CHIP). It’s clear that Americans are relying on these vital programs to keep them and their loved ones healthy.
I want your opinion: should Congress expand Medicaid and CHIP?
Yes
No
UnsureSubmit survey to sign up for updates on my work in Congress.*
No one should lose access to health care because of red tape or bureaucratic delays. The unwinding of Medicaid is the single largest health coverage transition event since the first open enrollment period of the ACA, and we should do everything possible to prevent people from slipping through the cracks and losing critical coverage simply because they don’t have the right paperwork or don’t know what steps to take to work through the red tape. According to KFF.org, over 21 million Medicaid enrollees have been disenrolled as of May 1, 2024 with more than 680,000 cases in Michigan alone.
To help address this, I joined my colleague Congressman Frank Pallone to introduce the Stabilize Medicaid and CHIP Coverage Act to provide 12 months of continuous coverage for individuals receiving health care through Medicaid or CHIP.
Every American has a right to quality healthcare. Plain and simple. I feel very strongly that access to healthcare is a right in this country and not a privilege. Before Medicare and Medicaid, the poor, the elderly, and those with disabilities in America were forced to fend for themselves. Expanding Medicare and Medicaid is one of the fastest and most effective ways to fix our broken healthcare system and prevent more Americans from getting sick.
Hearing your thoughts and concerns is important to me.
<clip>
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.


















